13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001623624
Total reported value
$306.0M
$306.0M
15 檔
57.2%
In Q1 2026, PSquared Asset Management AG's U.S. equity holdings reached a combined market value of $306.0M, distributed across 15 disclosed stock positions.
In Q1 2026, PSquared Asset Management AG displayed an active expansion posture, initiating 8 new positions and adding to 7 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | WBD | Warner Bros Discovery Inc | Stock-Comm Services | 15.89% | +3.97% | +7.94% | |
| 2 | IHS | IHS Holding Limited | Stock-Other | 12.44% | -0.80% | — | |
| 3 | SLSR | Solaris Resources Inc | Stock-Other | 12.27% | -1.05% | +3.06% | |
| 4 | HO1 | Hologic Inc | Stock-Other | 10.68% | -10.68% | EXIT | |
| 5 | NSC | Norfolk Southern CORP | Stock-Industrials | 9.62% | +0.22% | +4.69% | |
| 6 | GTLS | Chart Industries Inc | Stock-Industrials | 8.45% | -8.45% | EXIT | |
| 7 | AAUC | Allied Gold CORP | Stock-Other | 7.97% | -7.97% | EXIT | |
| 8 | AM6 | Amicus Therapeutics Inc | Stock-Other | 5.54% | -5.54% | EXIT | |
| 9 | PEN | Penumbra Inc | Stock-Healthcare | 4.89% | -4.89% | EXIT | |
| 10 | RVMD | Revolution Medicines Inc | Stock-Healthcare | 4.68% | +0.37% | — | |
| 11 | PRA | Proassurance CORP | Stock-Other | 3.17% | -3.17% | EXIT | |
| 12 | ACLXGBX | Arcellx Inc | Stock-Other | 2.21% | -2.21% | EXIT | |
| 13 | OLPX | Olaplex Holdings Inc | Stock-Other | 1.00% | -1.00% | EXIT | |
| 14 | ABVX | Abivax Sa-adr | Stock-Other | 0.63% | +1.16% | +6650.00% | |
| 15 | GPCR | Structure Therapeutics Inc | Stock-Other | 0.59% | +0.06% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ABVX | Abivax Sa-adr | +0.5% | +6650.00% | Add |
| 2 | PRA | Proassurance CORP | -0.7% | +6.30% | Add |
| 3 | AM6 | Amicus Therapeutics Inc | -1.5% | +4.88% | Add |
| 4 | GTLS | Chart Industries Inc | -2.2% | +6.10% | Add |
| 5 | SLSR | Solaris Resources Inc | -2.6% | +3.06% | Add |
| 6 | NSC | Norfolk Southern CORP | -2.8% | +4.69% | Add |
| 7 | WBD | Warner Bros Discovery Inc | -4.9% | +7.94% | Add |
| 8 | IHS | IHS Holding Limited | — | NEW | New buy |
| 9 | HO1 | Hologic Inc | — | NEW | New buy |
| 10 | AAUC | Allied Gold CORP | — | NEW | New buy |
| 11 | COMP | Compass Inc - Class A | — | EXIT | Sold out |
| 12 | BL | Blackline Inc | — | EXIT | Sold out |
| 13 | PEN | Penumbra Inc | — | NEW | New buy |
| 14 | RVMD | Revolution Medicines Inc | — | NEW | New buy |
| 15 | DBRG | Digitalbridge Group Inc | — | EXIT | Sold out |
| 16 | RNAGBP | Avidity Biosciences Inc | — | EXIT | Sold out |
| 17 | ACLXGBX | Arcellx Inc | — | NEW | New buy |
| 18 | FWRD | Forward Air CORP | — | EXIT | Sold out |
| 19 | OLPX | Olaplex Holdings Inc | — | NEW | New buy |
| 20 | GPCR | Structure Therapeutics Inc | — | NEW | New buy |
According to official SEC Form 13F filings, PSquared Asset Management AG reported a total U.S. public equity portfolio value of $306.0M across 15 disclosed positions in Q1 2026.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including WBD, IHS, SLSR) accounted for 57.2% of total reported equity market value during Q1 2026.
Top New Position Initiated
IHS
市值: $35.7M
Top Position Liquidated / Trimmed
COMP
前期市值: $18.5M
During Q1 2026, PSquared Asset Management AG's top holdings by market value included WBD (15.9%)、IHS (12.4%)、SLSR (12.3%). The largest single position, WBD, represented 15.9% of total portfolio value.
In Q1 2026, PSquared Asset Management AG made 20 total portfolio adjustments, initiating 8 new buys, adding to 7 positions, trimming 0 holdings, and fully liquidating 5 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.